Lv52
860 积分 2024-03-26 加入
Sample Size Calculations for the Development of Biosimilar Products
4天前
已完结
A Randomized, Double‐Blind, Parallel Controlled, Single‐Dose Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of the Infliximab Biosimilar CMAB008 and the Reference Product in Healthy Chinese Male Subjects
4天前
已完结
A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment
7天前
已完结
Innovative Design and Analysis for PK/PD Biosimilar Bridging Studies with Multiple References
8天前
已完结
Drug-drug interaction potential of SH-1028, a third-generation EGFR-TKI: in vitro and clinical trials
12天前
已完结
Phase 1 study to evaluate the effects of rifampin or itraconazole on the pharmacokinetics of limertinib (ASK120067), a novel mutant-selective inhibitor of the epidermal growth factor receptor in healthy Chinese subjects
12天前
已完结
Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers
12天前
已完结
Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs
13天前
已完结
Dosing and Monitoring NovoSeven® Treatment
2个月前
已完结
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry
2个月前
已完结
皖公网安备34019202002308
